145 related articles for article (PubMed ID: 17984998)
1. Variants in circadian genes and prostate cancer risk: a population-based study in China.
Chu LW; Zhu Y; Yu K; Zheng T; Yu H; Zhang Y; Sesterhenn I; Chokkalingam AP; Danforth KN; Shen MC; Stanczyk FZ; Gao YT; Hsing AW
Prostate Cancer Prostatic Dis; 2008; 11(4):342-8. PubMed ID: 17984998
[TBL] [Abstract][Full Text] [Related]
2. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.
Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of DNA repair genes and prostate cancer: a population-based study.
Ritchey JD; Huang WY; Chokkalingam AP; Gao YT; Deng J; Levine P; Stanczyk FZ; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1703-9. PubMed ID: 16030105
[TBL] [Abstract][Full Text] [Related]
4. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
[TBL] [Abstract][Full Text] [Related]
5. Vasectomy and prostate cancer risk in China.
Hsing AW; Wang RT; Gu FL; Lee M; Wang T; Leng TJ; Spitz M; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):285-8. PubMed ID: 8061575
[TBL] [Abstract][Full Text] [Related]
6. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
[TBL] [Abstract][Full Text] [Related]
7. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
[TBL] [Abstract][Full Text] [Related]
8. CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population.
Zhenhua L; Tsuchiya N; Narita S; Inoue T; Horikawa Y; Kakinuma H; Kato T; Ogawa O; Habuchi T
Cancer Lett; 2005 Jul; 225(2):237-43. PubMed ID: 15876487
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.
Choi JY; Neuhouser ML; Barnett M; Hudson M; Kristal AR; Thornquist M; King IB; Goodman GE; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1115-20. PubMed ID: 17548672
[TBL] [Abstract][Full Text] [Related]
10. Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival.
Hayes VM; Severi G; Southey MC; Padilla EJ; English DR; Hopper JL; Giles GG; Sutherland RL
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1223-5. PubMed ID: 16775185
[TBL] [Abstract][Full Text] [Related]
11. Association of XPD polymorphisms with prostate cancer in Taiwanese patients.
Bau DT; Wu HC; Chiu CF; Lin CC; Hsu CM; Wang CL; Wang RF; Tsai FJ
Anticancer Res; 2007; 27(4C):2893-6. PubMed ID: 17695467
[TBL] [Abstract][Full Text] [Related]
12. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
Paz-y-Miño C; Witte T; Robles P; Llumipanta W; Díaz M; Arévalo M
Cancer Genet Cytogenet; 2009 Mar; 189(2):71-6. PubMed ID: 19215786
[TBL] [Abstract][Full Text] [Related]
13. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population.
FitzGerald LM; Thomson R; Polanowski A; Patterson B; McKay JD; Stankovich J; Dickinson JL
Prostate; 2008 Sep; 68(13):1373-9. PubMed ID: 18537123
[TBL] [Abstract][Full Text] [Related]
14. TSP1 and MMP9 genetic variants in sporadic prostate cancer.
Sfar S; Saad H; Mosbah F; Gabbouj S; Chouchane L
Cancer Genet Cytogenet; 2007 Jan; 172(1):38-44. PubMed ID: 17175378
[TBL] [Abstract][Full Text] [Related]
15. An A/G polymorphism of core 2 branching enzyme gene is associated with prostate cancer.
Wang L; Mitoma J; Tsuchiya N; Narita S; Horikawa Y; Habuchi T; Imai A; Ishimura H; Ohyama C; Fukuda M
Biochem Biophys Res Commun; 2005 Jun; 331(4):958-63. PubMed ID: 15882971
[TBL] [Abstract][Full Text] [Related]
16. Period3 structural variation: a circadian biomarker associated with breast cancer in young women.
Zhu Y; Brown HN; Zhang Y; Stevens RG; Zheng T
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):268-70. PubMed ID: 15668506
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer and vasectomy: a hospital-based case-control study in China, Nepal and the Republic of Korea.
Schwingl PJ; Meirik O; Kapp N; Farley TM;
Contraception; 2009 May; 79(5):363-8. PubMed ID: 19341848
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
19. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
[TBL] [Abstract][Full Text] [Related]
20. V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.
Boger-Megiddo I; Weiss NS; Barnett MJ; Goodman GE; Chen C
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):286-91. PubMed ID: 18268111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
